Processa Pharmaceuticals Inc (NASDAQ: PCSA): Reassessing Prospects
Processa Pharmaceuticals Inc (PCSA) concluded trading on Thursday at a closing price of $0.65, with 4.06 million shares of worth about $2.64 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -71.28% during that period and on January 30, 2025 the price saw a […]
Processa Pharmaceuticals Inc (NASDAQ: PCSA) Is Getting Increasingly Hard To Ignore
Walleye Capital LLC recently announced the acquisition of new stake in Processa Pharmaceuticals Inc (NASDAQ:PCSA). The institutional investor has increased its shareholding in the Healthcare company by 14.36% to 0.42 million shares with purchase of 52640.0 shares. This fresh investment now brings its stake to 1.70% valued currently at $0.14 million. In addition, Geode Capital […]
